Ralliant Corporation $RAL Shares Acquired by Hudson Bay Capital Management LP

Hudson Bay Capital Management LP lifted its holdings in Ralliant Corporation (NYSE:RAL) by 278.8% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 179,891 shares of the company’s stock after purchasing an additional 132,403 shares during the period. Hudson Bay Capital Management LP owned approximately 0.16% of Ralliant worth $7,867,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the business. Westfuller Advisors LLC acquired a new stake in Ralliant during the 3rd quarter worth approximately $26,000. Palisade Asset Management LLC acquired a new position in shares of Ralliant in the third quarter worth $26,000. Manchester Capital Management LLC purchased a new stake in shares of Ralliant during the second quarter worth $29,000. UMB Bank n.a. purchased a new stake in shares of Ralliant during the third quarter worth $29,000. Finally, BOKF NA acquired a new stake in shares of Ralliant in the third quarter valued at $29,000.

Insider Activity at Ralliant

In other news, SVP Karen M. Bick sold 5,485 shares of the business’s stock in a transaction dated Tuesday, March 3rd. The shares were sold at an average price of $45.00, for a total transaction of $246,825.00. Following the transaction, the senior vice president directly owned 46,756 shares in the company, valued at $2,104,020. The trade was a 10.50% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP Amir A. Kazmi purchased 2,545 shares of the business’s stock in a transaction that occurred on Friday, February 6th. The shares were purchased at an average cost of $39.27 per share, with a total value of $99,942.15. Following the completion of the acquisition, the senior vice president directly owned 39,699 shares of the company’s stock, valued at $1,558,979.73. This represents a 6.85% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have bought 8,145 shares of company stock worth $332,233 in the last 90 days.

Analysts Set New Price Targets

RAL has been the subject of a number of recent research reports. Royal Bank Of Canada decreased their target price on Ralliant from $52.00 to $41.00 and set a “sector perform” rating for the company in a report on Friday, February 6th. Morgan Stanley reaffirmed an “overweight” rating and issued a $45.00 price target on shares of Ralliant in a research report on Friday, February 6th. Barclays decreased their price objective on Ralliant from $60.00 to $52.00 and set an “overweight” rating for the company in a research note on Monday, February 9th. Zacks Research downgraded Ralliant from a “hold” rating to a “strong sell” rating in a research report on Monday, February 9th. Finally, Truist Financial cut their target price on shares of Ralliant from $62.00 to $49.00 and set a “buy” rating on the stock in a research note on Friday, February 6th. Seven research analysts have rated the stock with a Buy rating, three have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $50.50.

Ralliant Stock Down 4.2%

RAL stock opened at $40.78 on Friday. The company has a market cap of $4.56 billion and a price-to-earnings ratio of 20.81. The company has a fifty day moving average price of $47.29 and a 200 day moving average price of $46.70. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.84 and a quick ratio of 0.58. Ralliant Corporation has a 12 month low of $37.27 and a 12 month high of $57.02.

Ralliant (NYSE:RAL) last released its earnings results on Wednesday, February 4th. The company reported $0.69 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. The company had revenue of $554.60 million during the quarter, compared to analyst estimates of $543.04 million. Ralliant’s quarterly revenue was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 23rd. Shareholders of record on Monday, March 9th will be given a dividend of $0.05 per share. The ex-dividend date is Monday, March 9th. This represents a $0.20 dividend on an annualized basis and a yield of 0.5%. Ralliant’s dividend payout ratio is presently 10.20%.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.